Human Hepatic CD56bright NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8+ T Cells

Liver-resident CD56brightCD16- natural killer (NK) cells are enriched in the human liver and are phenotypically distinct from their blood counterparts. Although these cells are capable of rapid cytotoxic effector activity, their functional role remains unclear. We hypothesise that they may contribut...

Full description

Bibliographic Details
Main Authors: Gráinne Jameson, Cathal Harmon, Rhyla Mae Santiago, Diarmaid D. Houlihan, Tom K. Gallagher, Lydia Lynch, Mark W. Robinson, Cliona O’Farrelly
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.921212/full
_version_ 1818536681175777280
author Gráinne Jameson
Cathal Harmon
Rhyla Mae Santiago
Diarmaid D. Houlihan
Tom K. Gallagher
Lydia Lynch
Mark W. Robinson
Cliona O’Farrelly
Cliona O’Farrelly
author_facet Gráinne Jameson
Cathal Harmon
Rhyla Mae Santiago
Diarmaid D. Houlihan
Tom K. Gallagher
Lydia Lynch
Mark W. Robinson
Cliona O’Farrelly
Cliona O’Farrelly
author_sort Gráinne Jameson
collection DOAJ
description Liver-resident CD56brightCD16- natural killer (NK) cells are enriched in the human liver and are phenotypically distinct from their blood counterparts. Although these cells are capable of rapid cytotoxic effector activity, their functional role remains unclear. We hypothesise that they may contribute to immune tolerance in the liver during transplantation. RNA sequencing was carried out on FACS sorted NK cell subpopulations from liver perfusates (n=5) and healthy blood controls (n=5). Liver-resident CD56brightCD16+/- NK cells upregulate genes associated with tissue residency. They also upregulate expression of CD160 and LY9, both of which encode immune receptors capable of activating NK cells. Co-expression of CD160 and Ly9 on liver-resident NK cells was validated using flow cytometry. Hepatic NK cell cytotoxicity against allogenic T cells was tested using an in vitro co-culture system of liver perfusate-derived NK cells and blood T cells (n=10-13). In co-culture experiments, hepatic NK cells but not blood NK cells induced significant allogenic T cell death (p=0.0306). Allogenic CD8+ T cells were more susceptible to hepatic NK cytotoxicity than CD4+ T cells (p<0.0001). Stimulation of hepatic CD56bright NK cells with an anti-CD160 agonist mAb enhanced this cytotoxic response (p=0.0382). Our results highlight a role for donor liver NK cells in regulating allogenic CD8+ T cell activation, which may be important in controlling recipient CD8+ T cell-mediated rejection post liver-transplant.
first_indexed 2024-12-11T18:41:04Z
format Article
id doaj.art-d85721e6345648c9a722293ac2094e71
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T18:41:04Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-d85721e6345648c9a722293ac2094e712022-12-22T00:54:36ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-07-011310.3389/fimmu.2022.921212921212Human Hepatic CD56bright NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8+ T CellsGráinne Jameson0Cathal Harmon1Rhyla Mae Santiago2Diarmaid D. Houlihan3Tom K. Gallagher4Lydia Lynch5Mark W. Robinson6Cliona O’Farrelly7Cliona O’Farrelly8School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, IrelandBrigham and Women’s Hospital, Harvard Medical School, Boston, MA, United StatesDepartment of Biology, Kathleen Lonsdale Institute of Human Health Research, Maynooth University, Maynooth, IrelandLiver Unit, St. Vincent’s University Hospital, Dublin, IrelandHepatopancreaticobiliary Group, St. Vincent’s University Hospital, Dublin, IrelandBrigham and Women’s Hospital, Harvard Medical School, Boston, MA, United StatesDepartment of Biology, Kathleen Lonsdale Institute of Human Health Research, Maynooth University, Maynooth, IrelandSchool of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, IrelandSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, IrelandLiver-resident CD56brightCD16- natural killer (NK) cells are enriched in the human liver and are phenotypically distinct from their blood counterparts. Although these cells are capable of rapid cytotoxic effector activity, their functional role remains unclear. We hypothesise that they may contribute to immune tolerance in the liver during transplantation. RNA sequencing was carried out on FACS sorted NK cell subpopulations from liver perfusates (n=5) and healthy blood controls (n=5). Liver-resident CD56brightCD16+/- NK cells upregulate genes associated with tissue residency. They also upregulate expression of CD160 and LY9, both of which encode immune receptors capable of activating NK cells. Co-expression of CD160 and Ly9 on liver-resident NK cells was validated using flow cytometry. Hepatic NK cell cytotoxicity against allogenic T cells was tested using an in vitro co-culture system of liver perfusate-derived NK cells and blood T cells (n=10-13). In co-culture experiments, hepatic NK cells but not blood NK cells induced significant allogenic T cell death (p=0.0306). Allogenic CD8+ T cells were more susceptible to hepatic NK cytotoxicity than CD4+ T cells (p<0.0001). Stimulation of hepatic CD56bright NK cells with an anti-CD160 agonist mAb enhanced this cytotoxic response (p=0.0382). Our results highlight a role for donor liver NK cells in regulating allogenic CD8+ T cell activation, which may be important in controlling recipient CD8+ T cell-mediated rejection post liver-transplant.https://www.frontiersin.org/articles/10.3389/fimmu.2022.921212/fullNK cellresidentCD8+ T celllivertransplanttolerance
spellingShingle Gráinne Jameson
Cathal Harmon
Rhyla Mae Santiago
Diarmaid D. Houlihan
Tom K. Gallagher
Lydia Lynch
Mark W. Robinson
Cliona O’Farrelly
Cliona O’Farrelly
Human Hepatic CD56bright NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8+ T Cells
Frontiers in Immunology
NK cell
resident
CD8+ T cell
liver
transplant
tolerance
title Human Hepatic CD56bright NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8+ T Cells
title_full Human Hepatic CD56bright NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8+ T Cells
title_fullStr Human Hepatic CD56bright NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8+ T Cells
title_full_unstemmed Human Hepatic CD56bright NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8+ T Cells
title_short Human Hepatic CD56bright NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8+ T Cells
title_sort human hepatic cd56bright nk cells display a tissue resident transcriptional profile and enhanced ability to kill allogenic cd8 t cells
topic NK cell
resident
CD8+ T cell
liver
transplant
tolerance
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.921212/full
work_keys_str_mv AT grainnejameson humanhepaticcd56brightnkcellsdisplayatissueresidenttranscriptionalprofileandenhancedabilitytokillallogeniccd8tcells
AT cathalharmon humanhepaticcd56brightnkcellsdisplayatissueresidenttranscriptionalprofileandenhancedabilitytokillallogeniccd8tcells
AT rhylamaesantiago humanhepaticcd56brightnkcellsdisplayatissueresidenttranscriptionalprofileandenhancedabilitytokillallogeniccd8tcells
AT diarmaiddhoulihan humanhepaticcd56brightnkcellsdisplayatissueresidenttranscriptionalprofileandenhancedabilitytokillallogeniccd8tcells
AT tomkgallagher humanhepaticcd56brightnkcellsdisplayatissueresidenttranscriptionalprofileandenhancedabilitytokillallogeniccd8tcells
AT lydialynch humanhepaticcd56brightnkcellsdisplayatissueresidenttranscriptionalprofileandenhancedabilitytokillallogeniccd8tcells
AT markwrobinson humanhepaticcd56brightnkcellsdisplayatissueresidenttranscriptionalprofileandenhancedabilitytokillallogeniccd8tcells
AT clionaofarrelly humanhepaticcd56brightnkcellsdisplayatissueresidenttranscriptionalprofileandenhancedabilitytokillallogeniccd8tcells
AT clionaofarrelly humanhepaticcd56brightnkcellsdisplayatissueresidenttranscriptionalprofileandenhancedabilitytokillallogeniccd8tcells